Gyre Therapeutics, Inc. (GYRE) SEC Filings — 2025
13 SEC filings for Gyre Therapeutics, Inc. (GYRE) in 2025.
Filings
- Gyre Therapeutics' Q3 Net Income Soars, Cash Reserves Bolstered — 10-Q · Nov 7, 2025
- Gyre Therapeutics, Inc. Files 8-K — 8-K · Sep 10, 2025
- Gyre Therapeutics Files 8-K on Director/Officer Changes — 8-K · Aug 22, 2025
- GYRE's Losses Widen Amid R&D Push, No Revenue Reported — 10-Q · Aug 11, 2025
- Gyre Therapeutics Files 8-K on Shareholder Vote — 8-K · Jun 6, 2025
- Gyre Therapeutics Enters Material Definitive Agreement — 8-K · May 23, 2025
- Gyre Therapeutics Updates Corporate Address and Contact Info — 8-K · May 22, 2025
- Gyre Therapeutics Files Q1 2025 10-Q — 10-Q · May 9, 2025
- Gyre Therapeutics Files 8-K — 8-K · Apr 28, 2025
- Gyre Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 21, 2025
- Gyre Therapeutics Files 8-K on Financials — 8-K · Mar 17, 2025
- Gyre Therapeutics Files 8-K on Financials — 8-K · Feb 18, 2025
- Gyre Therapeutics Files 8-K with Officer/Director Changes — 8-K · Jan 6, 2025